Investor-ready strategy: Integrated evidence planning to maximize commercial opportunity
Unlock the path to market success with Parexel's Integrated Evidence Generation Planning (IEGP) webinar. In today's challenging funding environment, biotech developers need more than just clinical data to attract investors and acquisition partners. Our experts will guide you through practical steps to identify and close high-value evidence gaps, streamline clinical development, and maximize valuation. Learn how to develop a robust evidence package that extends beyond clinical data, demonstrating confidence in your product's clinical and commercial potential.
Discover when, why, and how to implement an IEGP that positions your organization for its next milestone. Our webinar covers strategies for effective stakeholder communication, leveraging Real World Evidence throughout the product lifecycle, and choosing the right partnership model for IEGP development and execution. While we give oncology-specific examples, the insights shared are applicable across all therapeutic areas and product classes. Don't miss this opportunity to enhance your evidence generation strategy and accelerate your path to market success.
Related Insights
Playbook
Streamlining success: How integrated evidence planning transforms asset development
Feb 27, 2025
Playbook
Are you using real-world evidence?
Feb 1, 2023
Playbook
JCA in the EU: A roadmap for sponsors
Aug 5, 2025
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Whitepaper
The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations
Mar 9, 2023
Blog
Innovative modeling method could speed patient access to critical IO therapies
Jan 4, 2023
Blog
U.S. price reforms 2022: How can drug manufacturers best prepare for the Inflation Reduction Act?
Aug 17, 2022
Blog
Preparing for a new era in European Market Access
Jul 22, 2022
Related Insights
Playbook
Streamlining success: How integrated evidence planning transforms asset development
Feb 27, 2025
Playbook
Are you using real-world evidence?
Feb 1, 2023
Playbook
JCA in the EU: A roadmap for sponsors
Aug 5, 2025
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Whitepaper
The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations
Mar 9, 2023
Blog
Innovative modeling method could speed patient access to critical IO therapies
Jan 4, 2023
Blog
U.S. price reforms 2022: How can drug manufacturers best prepare for the Inflation Reduction Act?
Aug 17, 2022
Blog
Preparing for a new era in European Market Access
Jul 22, 2022